<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>health care group</title>
	<atom:link href="http://www.healthcaregroup.info/feed" rel="self" type="application/rss+xml" />
	<link>http://www.healthcaregroup.info</link>
	<description></description>
	<lastBuildDate>Tue, 21 Feb 2012 02:00:04 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Sedentary lifestyle cause for increase in knee and hip replacement surgery in the Arab world</title>
		<link>http://www.healthcaregroup.info/sedentary-lifestyle-cause-for-increase-in-knee-and-hip-replacement-surgery-in-the-arab-world/health-care/1215.html</link>
		<comments>http://www.healthcaregroup.info/sedentary-lifestyle-cause-for-increase-in-knee-and-hip-replacement-surgery-in-the-arab-world/health-care/1215.html#comments</comments>
		<pubDate>Tue, 21 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/sedentary-lifestyle-cause-for-increase-in-knee-and-hip-replacement-surgery-in-the-arab-world/health-care/1215.html</guid>
		<description><![CDATA[More than 40 international and regional joint reconstruction experts at ICJR-ME in Dubai.]]></description>
			<content:encoded><![CDATA[<p>More than 40 international and regional joint reconstruction experts at ICJR-ME in Dubai.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/sedentary-lifestyle-cause-for-increase-in-knee-and-hip-replacement-surgery-in-the-arab-world/health-care/1215.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Revolutionary Upper Limb Sports Medicine Symposium Finally Makes U.S. Soil</title>
		<link>http://www.healthcaregroup.info/revolutionary-upper-limb-sports-medicine-symposium-finally-makes-u-s-soil/health-care/1214.html</link>
		<comments>http://www.healthcaregroup.info/revolutionary-upper-limb-sports-medicine-symposium-finally-makes-u-s-soil/health-care/1214.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/revolutionary-upper-limb-sports-medicine-symposium-finally-makes-u-s-soil/health-care/1214.html</guid>
		<description><![CDATA[Conference Features Faculty from Brazil, Italy, Japan, Switzerland, Estonia, Australia, and the US.]]></description>
			<content:encoded><![CDATA[<p>Conference Features Faculty from Brazil, Italy, Japan, Switzerland, Estonia, Australia, and the US.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/revolutionary-upper-limb-sports-medicine-symposium-finally-makes-u-s-soil/health-care/1214.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EU and US Regulatory Update – Tykerb/Tyverb® (lapatinib)</title>
		<link>http://www.healthcaregroup.info/eu-and-us-regulatory-update-%e2%80%93-tykerbtyverb%c2%ae-lapatinib/health-care/1213.html</link>
		<comments>http://www.healthcaregroup.info/eu-and-us-regulatory-update-%e2%80%93-tykerbtyverb%c2%ae-lapatinib/health-care/1213.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/eu-and-us-regulatory-update-%e2%80%93-tykerbtyverb%c2%ae-lapatinib/health-care/1213.html</guid>
		<description><![CDATA[GlaxoSmithKline announced today that it has submitted regulatory applications in Europe and the US related to Tykerb/ Tyverb (lapatinib) and its use in combination with trastuzumab to treat patients with HER2 (ErbB2)-positive metastatic breast cancer.]]></description>
			<content:encoded><![CDATA[<p>GlaxoSmithKline announced today that it has submitted regulatory applications in Europe and the US related to Tykerb/ Tyverb (lapatinib) and its use in combination with trastuzumab to treat patients with HER2 (ErbB2)-positive metastatic breast cancer.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/eu-and-us-regulatory-update-%e2%80%93-tykerbtyverb%c2%ae-lapatinib/health-care/1213.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Washington Week: SGR Fix Passed</title>
		<link>http://www.healthcaregroup.info/washington-week-sgr-fix-passed/health-care/1212.html</link>
		<comments>http://www.healthcaregroup.info/washington-week-sgr-fix-passed/health-care/1212.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/washington-week-sgr-fix-passed/health-care/1212.html</guid>
		<description><![CDATA[WASHINGTON &#8211;Congress passed a bill to delay a scheduled 27% cut in Medicare payments by 10 months, and the president released his 2013 budget proposal, which requests a slight increase for health programs.]]></description>
			<content:encoded><![CDATA[<p>WASHINGTON &#8211;Congress passed a bill to delay a scheduled 27% cut in Medicare payments by 10 months, and the president released his 2013 budget proposal, which requests a slight increase for health programs.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/washington-week-sgr-fix-passed/health-care/1212.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug-Eluting Stent Approved for Diabetics</title>
		<link>http://www.healthcaregroup.info/drug-eluting-stent-approved-for-diabetics/health-care/1211.html</link>
		<comments>http://www.healthcaregroup.info/drug-eluting-stent-approved-for-diabetics/health-care/1211.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/drug-eluting-stent-approved-for-diabetics/health-care/1211.html</guid>
		<description><![CDATA[(MedPage Today) &#8212; The FDA has approved the Resolute Integrity drug-eluting stent, the first such stent to carry an indication for use in diabetics with coronary artery disease, according to a statement from the manufacturer.]]></description>
			<content:encoded><![CDATA[<p>(MedPage Today) &#8212; The FDA has approved the Resolute Integrity drug-eluting stent, the first such stent to carry an indication for use in diabetics with coronary artery disease, according to a statement from the manufacturer.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/drug-eluting-stent-approved-for-diabetics/health-care/1211.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mifepristone Wins Nod for Use in Cushing&#8217;s Disease</title>
		<link>http://www.healthcaregroup.info/mifepristone-wins-nod-for-use-in-cushings-disease/health-care/1210.html</link>
		<comments>http://www.healthcaregroup.info/mifepristone-wins-nod-for-use-in-cushings-disease/health-care/1210.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/mifepristone-wins-nod-for-use-in-cushings-disease/health-care/1210.html</guid>
		<description><![CDATA[(MedPage Today) &#8212; Mifepristone, best known as the &#8220;abortion pill&#8221; once called RU-486, has been approved for treating hyperglycemia associated with endogenous Cushing&#8217;s disease, the FDA said.]]></description>
			<content:encoded><![CDATA[<p>(MedPage Today) &#8212; Mifepristone, best known as the &#8220;abortion pill&#8221; once called RU-486, has been approved for treating hyperglycemia associated with endogenous Cushing&#8217;s disease, the FDA said.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/mifepristone-wins-nod-for-use-in-cushings-disease/health-care/1210.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EHR Adoption Way Up in Hospitals</title>
		<link>http://www.healthcaregroup.info/ehr-adoption-way-up-in-hospitals/health-care/1209.html</link>
		<comments>http://www.healthcaregroup.info/ehr-adoption-way-up-in-hospitals/health-care/1209.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/ehr-adoption-way-up-in-hospitals/health-care/1209.html</guid>
		<description><![CDATA[WASHINGTON (MedPage Today) &#8212; The number of hospitals using health information technology has more than doubled in the past two years, Health and Human Services (HHS) Secretary Kathleen Sebelius announced.]]></description>
			<content:encoded><![CDATA[<p>WASHINGTON (MedPage Today) &#8212; The number of hospitals using health information technology has more than doubled in the past two years, Health and Human Services (HHS) Secretary Kathleen Sebelius announced.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/ehr-adoption-way-up-in-hospitals/health-care/1209.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Reviewers Divided on Second Round for Diet Drug</title>
		<link>http://www.healthcaregroup.info/fda-reviewers-divided-on-second-round-for-diet-drug/health-care/1208.html</link>
		<comments>http://www.healthcaregroup.info/fda-reviewers-divided-on-second-round-for-diet-drug/health-care/1208.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/fda-reviewers-divided-on-second-round-for-diet-drug/health-care/1208.html</guid>
		<description><![CDATA[WASHINGTON (MedPage Today) &#8212; The weight-loss pill phentermine/topiramate (Qnexa) helps overweight and obese patients lose weight, but may also increase the risk for cleft palates in babies born to mothers who took the pill while pregnant, FDA reviewers said.]]></description>
			<content:encoded><![CDATA[<p>WASHINGTON (MedPage Today) &#8212; The weight-loss pill phentermine/topiramate (Qnexa) helps overweight and obese patients lose weight, but may also increase the risk for cleft palates in babies born to mothers who took the pill while pregnant, FDA reviewers said.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/fda-reviewers-divided-on-second-round-for-diet-drug/health-care/1208.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CardioGen Gets Boxed Warning</title>
		<link>http://www.healthcaregroup.info/cardiogen-gets-boxed-warning/health-care/1207.html</link>
		<comments>http://www.healthcaregroup.info/cardiogen-gets-boxed-warning/health-care/1207.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/cardiogen-gets-boxed-warning/health-care/1207.html</guid>
		<description><![CDATA[(MedPage Today) &#8212; CardioGen-82, a generator that produces the PET imaging agent rubidium-82, can return to market, says the FDA, but it must carry a new boxed warning.]]></description>
			<content:encoded><![CDATA[<p>(MedPage Today) &#8212; CardioGen-82, a generator that produces the PET imaging agent rubidium-82, can return to market, says the FDA, but it must carry a new boxed warning.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/cardiogen-gets-boxed-warning/health-care/1207.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Congress Passes 10-Month SGR Fix</title>
		<link>http://www.healthcaregroup.info/congress-passes-10-month-sgr-fix/health-care/1206.html</link>
		<comments>http://www.healthcaregroup.info/congress-passes-10-month-sgr-fix/health-care/1206.html#comments</comments>
		<pubDate>Sun, 19 Feb 2012 02:00:04 +0000</pubDate>
		<dc:creator>dani</dc:creator>
				<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.healthcaregroup.info/congress-passes-10-month-sgr-fix/health-care/1206.html</guid>
		<description><![CDATA[WASHINGTON (MedPage Today) &#8212; Congress has passed a compromise bill that would delay the impending 27% cut in Medicare pay rates for 10 months.]]></description>
			<content:encoded><![CDATA[<p>WASHINGTON (MedPage Today) &#8212; Congress has passed a compromise bill that would delay the impending 27% cut in Medicare pay rates for 10 months.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthcaregroup.info/congress-passes-10-month-sgr-fix/health-care/1206.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

